Jennifer Celio1, Françoise Ninane2, Olivier Bugnon1, Marie Paule Schneider3. 1. Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Switzerland; Community Pharmacy, Department of Ambulatory Care & Community Medicine, University of Lausanne, Switzerland. 2. Department of Ambulatory Care and Community Medicine, Lausanne University Hospital, Lausanne, Switzerland. 3. Community Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Switzerland; Community Pharmacy, Department of Ambulatory Care & Community Medicine, University of Lausanne, Switzerland. Electronic address: marie-paule.schneider@hospvd.ch.
Abstract
OBJECTIVES: Healthcare providers play an important role in addressing medication adherence. Pharmacists and nurses are qualified in this field even though they have different expertise. They both claim their role at the patient's side in collaboration with physicians. To avoid care duplication, such interprofessional collaborations must be carefully defined. The objectives of our review were to: 1) identify medication adherence-enhancing interventions involving pharmacists and nurses; 2) describe their respective roles. METHODS: Literature searches were conducted in PubMed/Medline, Embase, Cochrane Library. Screening criteria were: medication adherence-enhancing interventions, at least a pharmacist and nurse collaborating with/without other healthcare professionals, role description, outpatient settings, at least one oral treatment, adult patients. RESULTS: After screening, 21 references fulfilled the inclusion criteria. Pharmacists and nurses were both in a strategic position to identify eligible patients for adherence interventions, to assess and promote adherence. Pharmacists specifically ensured treatment efficacy, security and access, they provided information on the medication and related lifestyle advice. Nurses clinically co-managed patients with physicians; they also provided patients with information on their disease. CONCLUSIONS: Pharmacist-nurse medication adherence-enhancing interventions are rare and often in a nascent phase. PRACTICE IMPLICATIONS: The results of our review should help in designing new pharmacist-nurse medication adherence-enhancing interventions.
OBJECTIVES: Healthcare providers play an important role in addressing medication adherence. Pharmacists and nurses are qualified in this field even though they have different expertise. They both claim their role at the patient's side in collaboration with physicians. To avoid care duplication, such interprofessional collaborations must be carefully defined. The objectives of our review were to: 1) identify medication adherence-enhancing interventions involving pharmacists and nurses; 2) describe their respective roles. METHODS: Literature searches were conducted in PubMed/Medline, Embase, Cochrane Library. Screening criteria were: medication adherence-enhancing interventions, at least a pharmacist and nurse collaborating with/without other healthcare professionals, role description, outpatient settings, at least one oral treatment, adult patients. RESULTS: After screening, 21 references fulfilled the inclusion criteria. Pharmacists and nurses were both in a strategic position to identify eligible patients for adherence interventions, to assess and promote adherence. Pharmacists specifically ensured treatment efficacy, security and access, they provided information on the medication and related lifestyle advice. Nurses clinically co-managed patients with physicians; they also provided patients with information on their disease. CONCLUSIONS: Pharmacist-nurse medication adherence-enhancing interventions are rare and often in a nascent phase. PRACTICE IMPLICATIONS: The results of our review should help in designing new pharmacist-nurse medication adherence-enhancing interventions.
Authors: Elyne De Baetselier; Bart Van Rompaey; Luis M Batalha; Monica Bergqvist; Bozena Czarkowska-Paczek; Alberto De Santis; Nienke E Dijkstra; Maria I Fernandes; Izabela Filov; Vigdis Abrahamsen Grøndahl; Jana Heczkova; Ann Karin Helgesen; Michael Isfort; Susan Jordan; Igor Karnjus; Sarah Keeley; Petros Kolovos; Gero Langer; Manuel Lillo-Crespo; Vera Logan; Alba Malara; Gabriele Meyer; Andras Olah; Hana Padysakova; Mirko Prosen; Dorina Pusztai; Carolien G Sino; Styliani Tziaferi; Elena Ziakova; Tinne Dilles Journal: BMJ Open Date: 2020-06-03 Impact factor: 2.692
Authors: Cesar I Fernandez-Lazaro; Juan M García-González; David P Adams; Diego Fernandez-Lazaro; Juan Mielgo-Ayuso; Alberto Caballero-Garcia; Francisca Moreno Racionero; Alfredo Córdova; Jose A Miron-Canelo Journal: BMC Fam Pract Date: 2019-09-14 Impact factor: 2.497
Authors: Tinne Dilles; Jana Heczkova; Styliani Tziaferi; Ann Karin Helgesen; Vigdis Abrahamsen Grøndahl; Bart Van Rompaey; Carolien G Sino; Sue Jordan Journal: Int J Environ Res Public Health Date: 2021-06-02 Impact factor: 3.390